Johnson & Johnson stock dips on Trump drug-price deal — what to watch before Monday
New York, January 10, 2026, 10:58 ET — Market closed Johnson & Johnson shares fell 0.7% on Friday, closing at $204.39. The company said it reached an agreement with the U.S. government to lower drug prices in exchange for exemptions from tariffs. (reuters.com) The timing matters: drugmakers are heading into another round of pricing battles abroad, particularly in Europe, after agreeing to U.S. price concessions tied to what other wealthy countries pay. “You can’t force the Europeans to just all of a sudden spend more. But the deals do give the companies negotiating power,” said Marshall Gordon, a senior research